NIH-funded research Sbir 2 grant

Using cold technology to relieve pain after knee surgery

Official title: Neural Ice Technology for Treatment of Pain

Funded at Brixton Biosciences, INC. · NIH-11006862 · Data updated 2026-11-12

This study is testing a new way to help people manage pain after knee surgery without using opioids, by using a special freezing technique on certain nerves to provide lasting relief, making it easier and safer for patients.

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionBrixton Biosciences, INC.
NIH-funded
Lab location1 site (Cambridge, UNITED STATES)
Project startAugust 21, 2024
Project endJuly 31, 2026
Funding year2024
Award (this year)$998,787
NIH project number1R44AR084998-01
Project IDNIH-11006862 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults undergoing total knee arthroplasty due to severe osteoarthritis or rheumatic arthritis.

Less likely to help

Patients who are not undergoing knee surgery or those with contraindications to cryoneurolysis may not benefit from this research.

What this research studies

This research focuses on developing a new method to manage pain following total knee arthroplasty (TKA) without relying on opioids. The approach involves a technique called cryoneurolysis, which uses very low temperatures to freeze specific nerves, providing long-lasting pain relief. The goal is to create an injectable version of this treatment that is easier to administer and more effective than current methods. By reducing the need for opioid medications, this research aims to address the growing opioid crisis while improving patient outcomes.

Why it matters

Potential benefit: If successful, this research could provide a safe, effective, and non-opioid method for managing postoperative pain in knee surgery patients.

How similar studies have gone: Previous research has shown promise in using cryoneurolysis for pain management, indicating potential success for this novel injectable approach.

Where this research is happening

  • Brixton Biosciences, INC.
    Cambridge, United States
    Active

Researchers

  • Principal investigator: Sidoti, Charles — Brixton Biosciences, INC.
  • Study coordinator: Sidoti, Charles

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.